Aaron LeBeau

Assistant Professor, Pharmacology

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise related to UN SDGs

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

Dive into the research topics where Aaron LeBeau is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Finished
8 Active

COVID-19: Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses
Li, F. & LeBeau, A.
NEW YORK BLOOD CENTER, INC.
7/9/20 → 6/30/21
Project: Research project
Function and Clinical Utility of the HOXB13 Co-Factors MEIS1 and MEIS2 in Prostate Cancer Progression
LeBeau, A.
UNIVERSITY OF ILLINOIS CHICAGO
1/1/20 → 12/31/21
Project: Research project
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
LeBeau, A. & Li, F.
NIH NATIONAL CANCER INSTITUTE (NCI)
1/1/20 → 12/31/24
Project: Research project
CD133-Targeted Natural Killer Cell Therapy for Aggressive Prostate Cancer
LeBeau, A. & Moriarity, B. S.
U.S. DEPARTMENT OF DEFENSE
8/1/19 → 7/31/22
Project: Research project
Novel Radioimmunotherapy Strategies for Prostate Cancer
LeBeau, A. & Murugan, P.
NIH NATIONAL CANCER INSTITUTE (NCI)
7/1/19 → 6/30/24
Project: Research project

21 Article
1 Chapter
1 Comment/debate
1 Review article

Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer
Glumac, P. M., Gallant, J. P., Shapovalova, M., Li, Y., Murugan, P., Gupta, S., Coleman, I. M., Nelson, P. S., Dehm, S. M. & Lebeau, A. M., Mar 1 2020, In: Clinical Cancer Research. 26, 5, p. 1054-1064
Research output: Contribution to journal › Article › peer-review
Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography
Hintz, H. M., Gallant, J. P., Vander Griend, D. J., Coleman, I. M., Nelson, P. S. & Lebeau, A. M., Jul 7 2020, In: Clinical Cancer Research.
Research output: Contribution to journal › Article › peer-review
Correction: Exploiting the transcriptional specificity of the alphamethylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer (Oncotarget (2018) 9 (36693-36704) DOI: 10.18632/oncotarget.26401)
Shapovalova, M., Davydova, J., Henzler, C., Daniel, M., Dehm, S. M., Warlick, C. A. & LeBeau, A. M., Aug 1 2019, In: Oncotarget. 10, 47, p. 4920 1 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Development of a cross-reactive monoclonal antibody for detecting the tumor stroma
Hintz, H. M., Cowan, A. E., Shapovalova, M. & LeBeau, A., May 15 2019, In: Bioconjugate Chemistry. 30, 5, p. 1466-1476 11 p.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations
PEG10 promoter-driven expression of reporter genes enables molecular imaging of lethal prostate cancer
Shapovalova, M., Lee, J. K., Li, Y., Griend, D. J. V., Coleman, I. M., Nelson, P. S., Dehm, S. M. & LeBeau, A. M., Nov 1 2019, In: Cancer Research. 79, 21, p. 5668-5680 13 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations